## Background: The balance between matrix metalloproteinases (mmp) and the tissue inhibitors of metalloproteinases (timp) has been seen as important during tumor invasion and progression. the determination of these components needs a special strategy of tissue preparation. this analytical problem h
Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
โ Scribed by Hiro-omi Kanayama; Kin-ya Yokota; Yasushi Kurokawa; Yoshihide Murakami; Masaaki Nishitani; Susumu Kagawa
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 142 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Background:
Matrix metalloproteinase-2 (mmp-2), which degrades the extracellular matrix or the basement membrane, has an essential role in tumor invasion and metastasis. to evaluate the roles of mmp-2, its inhibitor (tissue inhibitor of metalloproteinase-2 [timp-2]), and its activator (membrane-type matrix metalloproteinase-1 [mt1-mmp]) in tumor invasion or as a prognostic factor in patients with bladder carcinoma, the authors investigated the expression of mmp-2, timp-2, and mt1-mmp in patients with bladder carcinoma.
Methods:
Tissues obtained from 41 patients with bladder carcinoma were used for analysis. expression of mmp-2, timp-2, mt1-mmp, and glyceraldehyde-3-phosphate dehydrogenase was examined by reverse transcriptase-polymerase chain reaction analysis. correlations between the levels of mmp-2, timp-2, and mt1-mmp expression and histologic findings or patient outcome were evaluated.
Results:
Expression of mmp-2 and timp-2 was significantly higher in muscle invasive pt2< or = bladder tumors than in pt1a tumors (mmp-2: p < 0.0005; timp-2: p < 0.005). moreover, high levels of mmp-2 and timp-2, as well as mt1-mmp expression, all were strongly associated with decreased survival (mmp-2: p < 0.0001; timp-2: p < 0.0001; and mt1-mmp: p < 0.005). even within the radically cystectomized muscle invasive pt2< or = tumor group, patients with a high expression of any of these three genes had a worse prognosis than those with low expression (mmp-2: p < 0.05; timp-2: p < 0.05; and mt1-mmp: p = 0.0641).
Conclusions:
Mmp-2 and timp-2 are believed to contribute to the invasive properties of bladder carcinoma. the authors report that expression of mmp-2, timp-2, and mt1-mmp are useful prognostic indicators in patients with bladder carcinoma and may be helpful in designing treatment protocols.
๐ SIMILAR VOLUMES
We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these
Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report
Degradation of the extracellular matrix (ECM) is an essential step in tumour invasion and metastasis. The matrix metalloproteinases (MMPs) each have different substrate specificities within the ECM and are important in its degradation. MMP activity is dependent on the levels of activated MMP and tis